Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaneka Eurogentec provides GMP-certified manufacturing of plasmid DNA, mRNA, recombinant proteins, oligonucleotides, peptides and antibody fragments for research through commercial use. They have expanded capacity for large-scale mRNA production suitable for late-stage clinical trials and commercial supply. The company does not develop its own drug pipeline but enables client programs across multiple modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaneka Eurogentec.